Lupin launches oral antibiotic Solosec in US

Lupin unveils oral antibiotic Solosec in U.S.

Drug major Lupin said it had unveiled Solosec, an oral antibiotic used in treating bacterial vaginosis (BV) in women, in the U.S. market, after receiving approval from the USFDA earlier. With more than four million women treated for BV in the U.S. annually, and only 50% completing 5 to 7 day treatments, there is a clear need for an effective, single-dose oral treatment, Lupin CEO Vinita Gupta said in a statement.pti